EZH2 and breast cancer: Our findings showed an over expression of epigenetic silencing complex PRC2/EED-EZH2 in breast cancer lymph node metastasis compared to primary tumor, suggesting epigenetic regulations mediated by PRC2 proteins may provide additional advantage for the outgrowth of lymph node metastasis.